Trospium / Xanomeline and Dihydrocodeine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Dihydrocodeine
No brand names on recordTrospium / Xanomeline
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Dihydrocodeine is an opioid pain medicine, and trospium (part of Cobenfy) has anticholinergic effects. Both of these can slow down your gut and make it harder to empty your bladder. When you take them together, those effects can add up. That means you may be more likely to get severe constipation or trouble urinating. In rare cases, very slow bowels can lead to a serious blockage called paralytic ileus.
The good news is this is a known combination your care team can watch for. Keep taking both as prescribed, drink plenty of fluids, and let your pharmacist or doctor know right away if you can't have a bowel movement, feel very bloated, or have trouble peeing.
Effect: Additive risk of urinary retention and severe constipation, potentially progressing to paralytic ileus.
Mechanism: Pharmacodynamic overlap. Dihydrocodeine (an opioid; not a relevant prodrug concern here) reduces GI motility and bladder emptying via mu-opioid effects, while trospium exerts antimuscarinic (anticholinergic) activity. Combined, these depress gut motility and detrusor function.
- Direction: Increased anticholinergic/constipating burden
- Onset: Unspecified
- Evidence: Theoretical; mechanism additive
- Severity: Major
Management: Monitor for reduced gastric motility, abdominal distension, and urinary retention. Encourage hydration and consider prophylactic bowel regimen. Dose may need individualization by the care team.
What happens
Increased risk of urinary retention and/or severe constipation leading to paralytic ileus
Interaction Deep Dive
Taking dihydrocodeine together with anticholinergics can heighten the likelihood of urinary retention and/or serious constipation, potentially progressing to paralytic ileus. When dihydrocodeine is given alongside anticholinergic agents, watch patients for indications of urinary retention or diminished gastric motility1.
Why it happens (mechanism)
Unknown
How to manage this interaction
This combination can make constipation and difficulty urinating more likely, so your care team will typically keep a closer eye on you.
- Keep taking both as prescribed unless your prescriber tells you otherwise.
- Your team may monitor you more closely for signs of a slow gut or a full bladder.
- Doses may need to be adjusted and individualized by your care team.
- Staying well hydrated and staying active can help keep things moving.
Call your pharmacist or doctor if you have no bowel movement for several days, severe bloating or belly pain, or trouble passing urine.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Trospium / Xanomeline and Dihydrocodeine together?
Taking dihydrocodeine with trospium can add up to more constipation and trouble urinating, rarely leading to a serious bowel blockage. Keep taking both as prescribed and report constipation or urinary trouble to your care team. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Trospium / Xanomeline and Dihydrocodeine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Trospium / Xanomeline and Dihydrocodeine interaction managed?
This combination can make constipation and difficulty urinating more likely, so your care team will typically keep a closer eye on you. Keep taking both as prescribed unless your prescriber tells you otherwise. Your team may monitor you more closely for signs of a slow gut or a full bladder. Doses may need to be adjusted and individualized by your care team. Staying well hydrated and staying activ… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Trospium / Xanomeline or Dihydrocodeine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: SYNALGOS(R)-DC oral capsules, aspirin, caffeine, dihydrocodeine bitartrate oral capsules. Sun Pharmaceuticals Industries Inc (per FDA), Cranbury, NJ, 2023. DailyMed
Keep reading about Dihydrocodeine
Keep reading about Trospium / Xanomeline
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist